Optimal population-level deployment of artemisinin combination therapies

被引：0
|
作者：
Nguyen, T. D. [1 ]
Olliaro, P. [2 ,3 ]
Dondorp, A. [4 ]
Baird, J. K. [5 ]
Lam, H. M. [1 ]
Farrar, J. [6 ]
Thwaites, G. E. [1 ]
White, N. J. [4 ]
Boni, M. F. [1 ]
机构：
[1] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam
[2] WHO TDR, Nuffield Dept Med, Geneva, Switzerland
[3] Univ Oxford, Oxford, England
[4] Mahidol Oxford Trop Med Res Unit MORU, Bangkok, Thailand
[5] Eijkman Oxford Clin Res Unit, Nuffield Dept Med, Jakarta, Indonesia
[6] Wellcome Trust Res Labs, London, England
来源：
TROPICAL MEDICINE & INTERNATIONAL HEALTH | 2015年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
PS1.029
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [41] Population-level consequences of risky dispersal
    Shaw, Allison K.
    Jalasvuori, Matti
    Kokko, Hanna
    OIKOS, 2014, 123 (08) : 1003 - 1013
  • [42] RESISTANCE GENES AT THE POPULATION-LEVEL - REPLY
    RICHARDS, CS
    KNIGHT, M
    LEWIS, FA
    PARASITOLOGY TODAY, 1993, 9 (06): : 217 - 217
  • [43] POPULATION DIFFERENTIATION AND THE CORRELATION AMONG TRAITS AT THE POPULATION-LEVEL
    GOODNIGHT, CJ
    AMERICAN NATURALIST, 1989, 133 (06): : 888 - 900
  • [44] The Population-level Effect of Adjuvant Therapies on Breast Cancer Recurrence: Application of the Trend-in-Trend Design
    Collin, Lindsay J.
    Waller, Lance A.
    Cronin-Fenton, Deirdre P.
    Ahern, Thomas P.
    Goodman, Michael
    McCullough, Lauren E.
    Kjaersgaard, Anders
    Woolpert, Kirsten M.
    Silliman, Rebecca A.
    Christiansen, Peer M.
    Ejlertsen, Bent
    Sorensen, Henrik Toft
    Lash, Timothy L.
    EPIDEMIOLOGY, 2024, 35 (05) : 660 - 666
  • [45] Evaluating population-level outcomes in Chronic Lymphocytic leukemia in the era of novel therapies using the SEER registry
    Muthiah, Chandrasekar
    Narra, Ravi
    Atallah, Ehab
    Juan, Wanlin
    Szabo, Aniko
    Murthy, Guru Subramanian Guru
    LEUKEMIA RESEARCH, 2024, 140
  • [46] Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects
    Chang, Larry W.
    Serwadda, David
    Quinn, Thomas C.
    Wawer, Maria J.
    Gray, Ronald H.
    Reynolds, Steven J.
    LANCET INFECTIOUS DISEASES, 2013, 13 (01): : 65 - 76
  • [47] Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
    Solange Youdom Whegang
    Rachida Tahar
    Vincent Ngane Foumane
    Georges Soula
    Henri Gwét
    Jean-Christophe Thalabard
    Leonardo K Basco
    Malaria Journal, 9
  • [48] Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
    Whegang, Solange Youdom
    Tahar, Rachida
    Foumane, Vincent Ngane
    Soula, Georges
    Gwet, Henri
    Thalabard, Jean-Christophe
    Basco, Leonardo K.
    MALARIA JOURNAL, 2010, 9
  • [49] Are artemisinin-based combination therapies effective against Plasmodium malariae?
    Calleri, Guido
    Balbiano, Rosanna
    Caramello, Pietro
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (06) : 1447 - 1448
  • [50] Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug!
    Nsanzabana, Christian
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2019, 4 (01)
12345